Finance Development Program Analyst
BioMarin Pharmaceutical Inc.
Summary
The BioMarin Financial Development Program (FDP) is designed to accelerate your growth as a finance and business leader while providing meaningful exposure to the biotech industry. Participants gain hands-on functional experience, build leadership capabilities, and contribute to impactful work across Finance. In addition to on-the-job learning, participants benefit from coaching, specialized training, and community engagement.
Job description
Summary
The BioMarin Financial Development Program (FDP) is designed to accelerate your growth as a finance and business leader while providing meaningful exposure to the biotech industry. Participants gain hands-on functional experience, build leadership capabilities, and contribute to impactful work across Finance. In addition to on-the-job learning, participants benefit from coaching, specialized training, and community engagement.
The FDP is a 24-month program consisting of two 12-month rotations. Rotations may include corporate finance, R&D finance, financial reporting, accounting, audit, treasury, and operations. Upon completion of the program, participants will be well positioned to advance their careers within Finance and across the broader organization.
Required Skills
- Motivated, organized and highly skilled with today's systems, applications, and platforms (Excel, PowerPoint, SharePoint, etc.)
- Independent worker and initiative-taker who enjoys problem solving and takes pride and accountability in their work product
- Excellent verbal and written communication skills
- Strong time management skills with the ability to manage various tasks, priorities, and timelines and adapt quickly to changing priorities
- Demonstrated leadership through academic, professional, volunteer, or extracurricular experiences, including taking ownership, influencing others, collaborating across teams, and delivering results with accountability
- Curiosity, learning agility, and enthusiasm for building a career in Finance
Desired Skills
- Complex Excel modeling skills
- PowerPoint visualization skills
- Familiarity with Copilot or other AI tools
Qualifications/Eligibility
- Undergraduate degree in Finance or Accounting
- Cumulative GPA of 3.2 or higher
- 0-2 years work experience
- Located in the San Francisco, CA, Bay Area, or willingness to relocate
- Must be available to work full-time, 40 hours a week
Program Benefits
- Broad exposure to multiple facets of corporate finance
- Experience in the dynamic biotech industry and within a mid-cap publicly traded company
- Opportunity to build a robust network across finance and other functions
- Targeted leadership and functional training
- Professional enrichment through quarterly "Development Day" programming
Requirements
- Undergraduate degree in Finance or Accounting
- Cumulative GPA of 3.2 or higher
- 0-2 years work experience
- Located in the San Francisco, CA, Bay Area, or willingness to relocate
- Must be available to work full-time, 40 hours a week
- Motivated, organized and highly skilled with today's systems, applications, and platforms (Excel, PowerPoint, SharePoint, etc.)
- Independent worker and initiative-taker who enjoys problem solving and takes pride and accountability in their work product
- Excellent verbal and written communication skills
- Strong time management skills with the ability to manage various tasks, priorities, and timelines and adapt quickly to changing priorities
- Demonstrated leadership through academic, professional, volunteer, or extracurricular experiences, including taking ownership, influencing others, collaborating across teams, and delivering results with accountability
- Curiosity, learning agility, and enthusiasm for building a career in Finance
Benefits
- Targeted leadership training
- Functional training
- Professional enrichment
- Development Day programming
Company overview
BioMarin Pharmaceutical Inc. is a leading global biotechnology company headquartered in San Rafael, California, specializing in the development and commercialization of innovative therapies for rare genetic diseases. Founded in 1997, the company has established itself as a pioneer in enzyme replacement therapies (ERTs) and genetic medicine, with a focus on addressing the root causes of serious, life-threatening conditions primarily affecting children. BioMarin's portfolio includes eight commercial therapies targeting various rare disorders, including mucopolysaccharidosis, phenylketonuria (PKU), achondroplasia, and hemophilia A. The company's groundbreaking work includes being the first to provide therapeutics for mucopolysaccharidosis type I and phenylketonuria. With approximately 3,000-3,500 employees worldwide and operations across North America, Europe, Asia Pacific, and South America, BioMarin maintains a strong commitment to transforming lives through genetic discovery. The company's research and development efforts continue to advance a robust pipeline of product candidates, applying a science-driven, patient-forward approach to address broader groups of genetic disorders.